Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council
BERWYN, PA — Virpax®Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced that it has entered into a cooperative research and development agreement (CRADA) with the National Institute of Neurological Disorders and Stroke …
Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council Read More